153 related articles for article (PubMed ID: 7354023)
1. Purification and properties of human coagulation factor VII.
Broze GJ; Majerus PW
J Biol Chem; 1980 Feb; 255(4):1242-7. PubMed ID: 7354023
[TBL] [Abstract][Full Text] [Related]
2. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
[TBL] [Abstract][Full Text] [Related]
3. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
Nakagaki T; Foster DC; Berkner KL; Kisiel W
Biochemistry; 1991 Nov; 30(45):10819-24. PubMed ID: 1932002
[TBL] [Abstract][Full Text] [Related]
4. Immunoaffinity purification of bovine factor VII.
Bach R; Oberdick J; Nemerson Y
Blood; 1984 Feb; 63(2):393-8. PubMed ID: 6362751
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
6. Regulation of factor VIIa activity in plasma: evidence that antithrombin III is the sole plasma protease inhibitor of human factor VIIa.
Kondo S; Kisiel W
Thromb Res; 1987 Apr; 46(2):325-35. PubMed ID: 3496682
[TBL] [Abstract][Full Text] [Related]
7. Activation and control of factor VII by activated factor X and thrombin. Isolation and characterization of a single chain form of factor VII.
Radcliffe R; Nemerson Y
J Biol Chem; 1975 Jan; 250(2):388-95. PubMed ID: 234427
[TBL] [Abstract][Full Text] [Related]
8. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation.
Sakai T; Lund-Hansen T; Paborsky L; Pedersen AH; Kisiel W
J Biol Chem; 1989 Jun; 264(17):9980-8. PubMed ID: 2785997
[TBL] [Abstract][Full Text] [Related]
9. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor).
Kisiel W; Fujikawa K; Davie EW
Biochemistry; 1977 Sep; 16(19):4189-94. PubMed ID: 901769
[TBL] [Abstract][Full Text] [Related]
10. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.
Rao LV; Rapaport SI
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6687-91. PubMed ID: 3261869
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of bovine factor VII.
Kisiel W; Davie EW
Biochemistry; 1975 Nov; 14(22):4928-34. PubMed ID: 1182130
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of human factor VII. Activation of factor VII by factor Xa.
Bajaj SP; Rapaport SI; Brown SF
J Biol Chem; 1981 Jan; 256(1):253-9. PubMed ID: 6778860
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of human factor VIIa-tissue factor by antithrombin III-heparin is enhanced by factor X on a human bladder carcinoma cell line.
Hamamoto T; Foster DC; Kisiel W
Int J Hematol; 1996 Jan; 63(1):51-63. PubMed ID: 8713577
[TBL] [Abstract][Full Text] [Related]
14. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
15. Characterization of bovine factor XIIa (activated Hageman factor).
Fujikawa K; Kurachi K; Davie EW
Biochemistry; 1977 Sep; 16(19):4182-8. PubMed ID: 901768
[TBL] [Abstract][Full Text] [Related]
16. Purification of Factor VII from bovine plasma. Reaction with tissue factor and activation of Factor X.
Jesty J; Nemerson Y
J Biol Chem; 1974 Jan; 249(2):509-15. PubMed ID: 4809529
[No Abstract] [Full Text] [Related]
17. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin.
Lawson JH; Butenas S; Ribarik N; Mann KG
J Biol Chem; 1993 Jan; 268(2):767-70. PubMed ID: 8419351
[TBL] [Abstract][Full Text] [Related]
18. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells.
Wildgoose P; Kisiel W
Blood; 1989 May; 73(7):1888-95. PubMed ID: 2785418
[TBL] [Abstract][Full Text] [Related]
19. Activation of a proteolytic system by a membrane lipoprotein: mechanism of action of tissue factor.
Nemerson Y; Esnouf MP
Proc Natl Acad Sci U S A; 1973 Feb; 70(2):310-4. PubMed ID: 4510277
[TBL] [Abstract][Full Text] [Related]
20. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
